financetom
Business
financetom
/
Business
/
Banco Santander Q3 Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Banco Santander Q3 Revenue Increases
Oct 29, 2025 2:58 AM

05:39 AM EDT, 10/29/2025 (MT Newswires) -- Banco Santander (SAN) reported Q3 earnings Wednesday of 0.23 euro ($0.27) per diluted share.

Four analysts polled by FactSet expected 0.22 euro.

Revenue for the quarter ended Sept. 30 was 15.27 billion euros, up from 15.14 billion euros a year earlier.

Analysts polled by FactSet expected 15.31 billion euros.

The company said it is confident it will meet its 2025 targets, including revenue of 62 billion euros and mid-high single-digit net fee income growth.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer
IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer
Jul 8, 2024
Monday, IDEAYA Biosciences Inc ( IDYA ) released clinical data for the IDE397 Phase 2 monotherapy expansion dose in methylthioadenosine phosphorylase-deletion urothelial and non-small cell lung cancer patients (NSCLC). “IDE397 is a potential first-in-class MAT2A inhibitor, that is being advanced as a monotherapy agent in priority MTAP-deletion solid tumor types and in high conviction rational combinations, including with Amgen’s investigational...
Update: ThreeD Capital Falls 9.6% as it Seeks $1.5 Million from a Private Placement
Update: ThreeD Capital Falls 9.6% as it Seeks $1.5 Million from a Private Placement
Jul 8, 2024
12:31 PM EDT, 07/08/2024 (MT Newswires) -- ThreeD Capital ( IDKFF ) said over the weekend that it is raising about $1.5 million in a private placement of share units. The venture-capital firm said it is offering nearly 5.6-million units priced at $0.27 each in the financing. Each unit consists of one share and a three-year warrant to buy a...
RBC Capital on Bausch + Lomb's Miebo, Xiidra, Prescription Numbers
RBC Capital on Bausch + Lomb's Miebo, Xiidra, Prescription Numbers
Jul 8, 2024
12:36 PM EDT, 07/08/2024 (MT Newswires) -- RBC Capital notes that total prescriptions (TRx) for Bausch + Lomb's ( BLCO ) prescription for dry eye disease (DED), Miebo, increased week over week, while Xiidra (also for dry eye) printed a year over year decline. Miebo TRx increased to 19,565 vs. last week's TRx of 16,580, notes analyst Douglas Miehm. As...
Second-Quarter Domestic Box Office Collections Miss Views Amid Thin Film Slate, B. Riley Says
Second-Quarter Domestic Box Office Collections Miss Views Amid Thin Film Slate, B. Riley Says
Jul 8, 2024
12:40 PM EDT, 07/08/2024 (MT Newswires) -- Second-quarter domestic box office revenues came in lower than expected because of a relatively thin film slate tied to production delays from last year's Hollywood strikes, B. Riley Securities said in a note emailed Monday. Box office collections totaled $1.95 billion for the just ended quarter, representing an annual decline of roughly 27%,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved